Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells

Código QR

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells

Jong Hwa Jun,1 Wern-Joo Sohn,2 Youngkyun Lee,2 Jae-Young Kim21Department of Ophthalmology, School of Medicine, Dongsan Medical Center, Keimyung University, 2Department of Oral Biochemistry, School of Dentistry, IHBR, Kyungpook National University, Daegu, South KoreaAbstract: The molecular a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jun JH, Sohn WJ, Lee Y, Kim JY
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Avastin bevacizumab lens epithelial cell transforming growth factor vascular endothelial growth factor Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/1e7ef79f18d54570841eaea4dcb062fb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
por: Saquib Naeem, et al.
Publicado: (2019)

Bevacizumab-Induced Geographic Tongue
por: Marta Martinez-Garcia, et al.
Publicado: (2021)

Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center
por: Jang K, et al.
Publicado: (2020)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
por: Alsaedi NG, et al.
Publicado: (2021)

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
por: Kartasasmita AS, et al.
Publicado: (2016)

Immunohistochemical Localization of Vascular Factors in Tooth Germ of Amphibian (Cynops pyrrhogaster)
por: Miwa,Yoko, et al.
Publicado: (2021)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat A, et al.
Publicado: (2021)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin HS, et al.
Publicado: (2020)

Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization
por: Lee JE, et al.
Publicado: (2017)

Vascular Endothelial Growth Factor as a Putative Biomarker of Depression in Asthmatics with Reversible Airway Narrowing
por: Krzysztof Gomułka, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan CS, et al.
Publicado: (2017)

Mesenchymal stem cell-derived exosomes inhibit the VEGF-A expression in human retinal vascular endothelial cells induced by high glucose
por: Guang-Hui He, et al.
Publicado: (2021)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
por: Blinder KJ, et al.
Publicado: (2017)

Vascular Endothelial Growth Factor in Unstimulated Saliva of the Patients with Minor Aphtha
por: S Seifi,, et al.
Publicado: (2012)

Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage
por: Jeong JH, et al.
Publicado: (2016)

Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
por: Abu-Yaghi NE, et al.
Publicado: (2020)

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics
por: Xiaoqing Ye, et al.
Publicado: (2021)

Vascular Endothelial Growth Factor Expression in Correlation with Stage Juvenile Nasopharyngeal Angiofibroma
por: Ifiq Budiyan Nazar, et al.
Publicado: (2021)

Immediate sequential bilateral intravitreal injections: an Indian perspective
por: Tripathy K
Publicado: (2017)

Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy
por: Faruk Nisic, et al.
Publicado: (2019)

Identificación de factor de crecimiento vascular endotelial en células glandulares de tejido prostético maligno y benigno: Relación con la recidiva tumoral al año de la prostatectomía
por: Acuña,Pedro, et al.
Publicado: (2013)

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
por: Niyazi Kilic, et al.
Publicado: (2015)

Actualización en el diagnóstico y terapéutica en hipertensión pulmonar arterial
por: Zagolin B,Mónica, et al.
Publicado: (2006)

Effects of Xylene on Respiratory Mucosa in Rats
por: Arslan,Eda, et al.
Publicado: (2016)

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
por: Wingard JB, et al.
Publicado: (2019)

Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction
por: Okawada H, et al.
Publicado: (2018)

Nephrotoxicity induced by vascular endothelial growth factor inhibitors
por: Shirinsadat Badri, et al.
Publicado: (2022)

Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
por: Kamilla Faritovna Idrisova, et al.
Publicado: (2022)

Vascular endothelial growth factor in the fluid of the anterior chamber of the eye in patients with diabetic retinopathy, cataract andneovascular glaucoma
por: Anatoliy Gennad'evich Kuz'min, et al.
Publicado: (2010)

Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study
por: Muto T, et al.
Publicado: (2019)

Effects of Vitamin E on the Epithelial-Mesenchymal Transition in Testicular Development Exposed to Valproic Acid
por: Conei,Daniel, et al.
Publicado: (2021)

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
por: Cheema MR, et al.
Publicado: (2021)

Compromiso renal en síndrome de Poems: Caso clínico
por: Vega,Jorge
Publicado: (2016)

Polymorphism of vascular endothelial growth factor gene (<i>VEGF</i>) and matrix metalloproteinase (<i>ММР</i>) genes in primary limb lymphedema
por: A. V. Shevchenko, et al.
Publicado: (2020)

Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
por: Lin CJ, et al.
Publicado: (2016)

Prospects for the treatment of diabetic retinopathy: Modulation of endothelial growth factor
por: Anatoliy Gennad'evich Kuzmin, et al.
Publicado: (2009)

Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
por: Soji Toda, et al.
Publicado: (2021)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
por: Dugel PU, et al.
Publicado: (2016)

Tratamiento de la retinopatía del prematuro con bevacizumab intravítreo
por: BANCALARI M,ALDO, et al.
Publicado: (2013)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
por: Yannuzzi NA, et al.
Publicado: (2019)